Evidence map›Paper›PMID 30317863›Full record

ReviewBehavior modification2020

Reward Network Modulation as a Mechanism of Change in Behavioral Activation.

Gabriela A Nagy, Paul Cernasov, Angela Pisoni, Erin Walsh, Gabriel S Dichter, Moria J Smoski

Open access · greenAbstract readReview
In one paragraph

Review in Behavior modification, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Depression Severity Moderates Reward Learning Among Smokers With Current or Past Major Depressive Disorder in a Smoking Cessation Randomized Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Gabriela A NagyDuke University School of Medicine, Durham, NC, USA.ORCID 0000-0001-8176-4341
Paul CernasovThe University of North Carolina at Chapel Hill, NC, USA.ORCID 0000-0001-7183-393X
Angela PisoniDuke University, Durham, NC, USA.
Erin WalshThe University of North Carolina at Chapel Hill, NC, USA.
Gabriel S DichterThe University of North Carolina at Chapel Hill, NC, USA.
Moria J SmoskiDuke University Medical Center, Durham, NC, USA.
University of North Carolina at Chapel Hill · USDuke University · USDuke Medical Center · US

Funding

Development of A Novel Transdiagnostic Intervention for AnhedoniaR33MH110027 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DICHTER, GABRIEL S, SMOSKI, MORIA J. · 2019 to 2021
$2.3M
NIMH NIH HHS R33 MH110027
6 · The paper itself

Abstract

Behavioral Activation (BA) is a contemporary third-wave psychosocial treatment approach that emphasizes helping individuals become more active in ways that are meaningful to them as a means of improving mood and quality of life. BA has been designated as a well-established, validated treatment for depression by the American Psychological Association following several decades of accumulated empirical support demonstrating that BA techniques successfully reduce depression symptoms and produce other desirable outcomes across a variety of populations and contexts. The purported mechanism of change underlying BA treatment lies in increasing activation, which in turn increases contact with positive reinforcement thereby reversing the cycle of depression. Current studies are further investigating how increasing activation and subsequent contact with mood reinforcers can influence mood and behavior. Specifically, there is growing evidence that BA modifies function of reward-related networks in the brain, and that these changes are associated with clinical improvement. Herein, we provide a brief history of BA, describe the primary components of BA treatment, and describe BA's purported mechanisms of change at behavioral, neural, and subjective activation levels. We present limitations as well as gaps in the current state of knowledge regarding mechanisms of action of BA.

Indexed as

AffectBehavior TherapyBrainNerve NetRewardHumansactivationanhedoniabehavioral activationmajor depressive disorderneural mechanismsreward processing

Identifiers

PMID30317863
PMCPMC7319253
OpenAlexW2898040649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.